Susquehanna International Group
VNDA icon

Susquehanna International Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Susquehanna International Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$713K Sell
103,202
-87,420
-46% -$674K ﹤0.01% 8771
2025
Q4 		$1.68M Buy
190,622
+60,662
+47% +$334K ﹤0.01% 6007
2025
Q3 		$649K Sell
129,960
-47,291
-27% -$219K ﹤0.01% 8379
2025
Q2 		$837K Buy
177,251
+18,471
+12% +$80.8K ﹤0.01% 7905
2025
Q1 		$729K Buy
158,780
+75,097
+90% +$350K ﹤0.01% 8044
2024
Q4 		$401K Buy
83,683
+403
+0.5% +$1.94K ﹤0.01% 9210
2024
Q3 		$391K Sell
83,280
-82,722
-50% -$443K ﹤0.01% 9044
2024
Q2 		$938K Buy
166,002
+9,590
+6% +$49.5K ﹤0.01% 6737
2024
Q1 		$643K Sell
156,412
-86,093
-36% -$345K ﹤0.01% 7905
2023
Q4 		$1.02M Sell
242,505
-379,495
-61% -$1.53M ﹤0.01% 6939
2023
Q3 		$2.69M Buy
622,000
+537,210
+634% +$2.98M ﹤0.01% 4579
2023
Q2 		$559K Sell
84,790
-8,522
-9% -$54.6K ﹤0.01% 8062
2023
Q1 		$634K Buy
93,312
+70,829
+315% +$498K ﹤0.01% 7990
2022
Q4 		$166K Sell
22,483
-31,288
-58% -$305K ﹤0.01% 10377
2022
Q3 		$531K Buy
53,771
+41,630
+343% +$440K ﹤0.01% 8327
2022
Q2 		$132K Sell
12,141
-46,816
-79% -$485K ﹤0.01% 11189
2022
Q1 		$667K Sell
58,957
-54,670
-48% -$719K ﹤0.01% 8215
2021
Q4 		$1.78M Buy
113,627
+71,139
+167% +$1.24M ﹤0.01% 5781
2021
Q3 		$728K Buy
42,488
+16,309
+62% +$286K ﹤0.01% 8405
2021
Q2 		$563K Sell
26,179
-19,325
-42% -$346K ﹤0.01% 9314
2021
Q1 		$683K Buy
45,504
+22,571
+98% +$365K ﹤0.01% 8731
2020
Q4 		$301K Sell
22,933
-30,503
-57% -$367K ﹤0.01% 9247
2020
Q3 		$516K Sell
53,436
-9,643
-15% -$103K ﹤0.01% 7602
2020
Q2 		$722K Sell
63,079
-41,907
-40% -$474K ﹤0.01% 6597
2020
Q1 		$1.09M Buy
104,986
+74,820
+248% +$928K ﹤0.01% 5210
2019
Q4 		$495K Sell
30,166
-40,766
-57% -$616K ﹤0.01% 7008
2019
Q3 		$942K Sell
70,932
-33,248
-32% -$463K ﹤0.01% 5812
2019
Q2 		$1.47M Sell
104,180
-71,324
-41% -$1.14M ﹤0.01% 4819
2019
Q1 		$3.23M Buy
+175,504
New +$4M ﹤0.01% 3028
2018
Q2 		– Sell
-18,755
Closed -$314K – 10496
2018
Q1 		$316K Sell
18,755
-8,693
-32% -$146K ﹤0.01% 7547
2017
Q4 		$417K Buy
+27,448
New +$407K ﹤0.01% 6977
2017
Q1 		– Sell
-100,912
Closed -$1.44M – 10051
2016
Q4 		$1.61M Sell
100,912
-51,387
-34% -$826K ﹤0.01% 4532
2016
Q3 		$2.53M Buy
152,299
+34,786
+30% +$468K ﹤0.01% 3166
2016
Q2 		$1.31M Buy
117,513
+106,085
+928% +$1.03M ﹤0.01% 4305
2016
Q1 		$96K Sell
11,428
-45,627
-80% -$374K ﹤0.01% 8450
2015
Q4 		$531K Sell
57,055
-13,810
-19% -$138K ﹤0.01% 6645
2015
Q3 		$799K Buy
70,865
+17,420
+33% +$213K ﹤0.01% 6207
2015
Q2 		$678K Sell
53,445
-109,447
-67% -$1.18M ﹤0.01% 7020
2015
Q1 		$1.51M Buy
162,892
+143,741
+751% +$1.62M ﹤0.01% 4898
2014
Q4 		$274K Sell
19,151
-48,646
-72% -$576K ﹤0.01% 8281
2014
Q3 		$704K Sell
67,797
-20,532
-23% -$269K ﹤0.01% 6589
2014
Q2 		$1.43M Sell
88,329
-3,119
-3% -$41.5K ﹤0.01% 5326
2014
Q1 		$1.49M Sell
91,448
-148,508
-62% -$2.11M ﹤0.01% 4815
2013
Q4 		$2.98M Buy
+239,956
New +$2.41M ﹤0.01% 3672
2013
Q3 		– Sell
-129,035
Closed -$1.38M – 8814
2013
Q2 		$1.04M Buy
+129,035
New +$869K ﹤0.01% 4919

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's VNDA Position: Q1 2026 in Review

Susquehanna International Group reduced its Vanda Pharmaceuticals (VNDA) stake by 46% in Q1 2026, selling an estimated $674K and leaving 103,202 shares worth $713K. The position accounts for ﹤0.01% of the portfolio, ranked #8771.

Susquehanna International Group first reported a position in VNDA in Q2 2013 and has held it in 45 quarters since. The position peaked at $3.23M in Q1 2019. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Susquehanna International Group held 103,202 shares of Vanda Pharmaceuticals worth $713K as of Q1 2026.
  • Susquehanna International Group sold 87,420 Vanda Pharmaceuticals shares in Q1 2026, an estimated $674K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8771 holding.
  • Susquehanna International Group first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 45 quarters since.
  • Susquehanna International Group's Vanda Pharmaceuticals position peaked at $3.23M in Q1 2019.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.